HK175495A - Crystalline salt of 4-(di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz[cd]indole - Google Patents

Crystalline salt of 4-(di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz[cd]indole Download PDF

Info

Publication number
HK175495A
HK175495A HK175495A HK175495A HK175495A HK 175495 A HK175495 A HK 175495A HK 175495 A HK175495 A HK 175495A HK 175495 A HK175495 A HK 175495A HK 175495 A HK175495 A HK 175495A
Authority
HK
Hong Kong
Prior art keywords
hippurate
amino
indole
tetrahydrobenz
propyl
Prior art date
Application number
HK175495A
Other languages
German (de)
English (en)
French (fr)
Inventor
Joseph Kress Thomas
Lee Varie David
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of HK175495A publication Critical patent/HK175495A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK175495A 1990-02-26 1995-11-16 Crystalline salt of 4-(di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz[cd]indole HK175495A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48518590A 1990-02-26 1990-02-26

Publications (1)

Publication Number Publication Date
HK175495A true HK175495A (en) 1995-11-24

Family

ID=23927224

Family Applications (1)

Application Number Title Priority Date Filing Date
HK175495A HK175495A (en) 1990-02-26 1995-11-16 Crystalline salt of 4-(di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz[cd]indole

Country Status (28)

Country Link
US (1) US5397799A (esLanguage)
EP (1) EP0444852B1 (esLanguage)
JP (1) JP3157007B2 (esLanguage)
KR (1) KR100208114B1 (esLanguage)
CN (1) CN1027503C (esLanguage)
AT (1) ATE126506T1 (esLanguage)
AU (1) AU629453B2 (esLanguage)
BR (1) BR9100767A (esLanguage)
CA (1) CA2037099C (esLanguage)
CY (1) CY1887A (esLanguage)
DE (1) DE69112099T2 (esLanguage)
DK (1) DK0444852T3 (esLanguage)
ES (1) ES2077796T3 (esLanguage)
FI (1) FI95464C (esLanguage)
GR (1) GR3017940T3 (esLanguage)
HK (1) HK175495A (esLanguage)
HU (1) HU217118B (esLanguage)
IE (1) IE67801B1 (esLanguage)
IL (1) IL97306A (esLanguage)
LV (1) LV10251B (esLanguage)
NO (1) NO174149C (esLanguage)
NZ (1) NZ237181A (esLanguage)
PT (1) PT96852B (esLanguage)
RU (2) RU2034837C1 (esLanguage)
SG (1) SG69975A1 (esLanguage)
TW (1) TW219933B (esLanguage)
YU (1) YU47594B (esLanguage)
ZA (1) ZA911258B (esLanguage)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97309A (en) * 1990-02-26 1996-11-14 Lilly Co Eli Intermediates for hexahydrobenz Úcd¾ indoles and process for the preparation of pure enantiomers thereof
IL97308A (en) * 1990-02-26 1996-10-31 Lilly Co Eli 6-Substituted-hexahydrobenz (cd) indoles process for their preparation and pharmaceutical compositions containing them
US5302612A (en) * 1990-02-26 1994-04-12 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
US5654324A (en) * 1991-03-28 1997-08-05 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[cd]indoles
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
TW248556B (esLanguage) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
UA53205C2 (en) * 2002-04-03 2006-06-15 Pharmatech Close Joint Stock C Antidepressant formulation and method for its manufacture
US7588924B2 (en) 2006-03-07 2009-09-15 Procter & Gamble Company Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase
MX2009000286A (es) * 2006-06-26 2009-03-20 Procter & Gamble Inhibidores de prolil hidroxilasa y metodos de uso.
KR20140095105A (ko) * 2009-11-06 2014-07-31 에르피오 세러퓨틱스 인코포레이티드 대장염 치료용 조성물 및 방법
NO2686520T3 (esLanguage) 2011-06-06 2018-03-17
RU2602498C2 (ru) 2011-06-06 2016-11-20 Акебиа Терапеутикс Инк. Соединения и композиции для стабилизации индуцируемого гипоксией фактора-2 альфа как способ лечения рака
HUE066123T2 (hu) 2013-06-13 2024-07-28 Akebia Therapeutics Inc Készítmények és módszerek anémia kezelésére
TW201946625A (zh) 2013-11-15 2019-12-16 美商阿克比治療有限公司 {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式，其組合物及用途
CN107427503A (zh) 2015-01-23 2017-12-01 阿克比治疗有限公司 2‑(5‑(3‑氟苯基)‑3‑羟基吡啶甲酰胺)乙酸的固体形式、其组合物及用途
US11324734B2 (en) 2015-04-01 2022-05-10 Akebia Therapeutics, Inc. Compositions and methods for treating anemia
JP7440989B2 (ja) 2018-05-09 2024-02-29 アケビア セラピューティクス インコーポレイテッド ２－［５－（３－クロロフェニル）－３－ヒドロキシピリジン－２－カルボニル］アミノ］酢酸を調製するための方法
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles

Also Published As

Publication number Publication date
RU2034837C1 (ru) 1995-05-10
YU32791A (sh) 1994-01-20
FI910895A0 (fi) 1991-02-25
DK0444852T3 (da) 1995-12-11
DE69112099D1 (de) 1995-09-21
KR910021375A (ko) 1991-12-20
IL97306A (en) 1996-10-16
CN1054589A (zh) 1991-09-18
NO174149B (no) 1993-12-13
FI910895L (fi) 1991-08-27
HU217118B (hu) 1999-11-29
IL97306A0 (en) 1992-05-25
NO174149C (no) 1994-03-23
CN1027503C (zh) 1995-01-25
GR3017940T3 (en) 1996-02-29
YU47594B (sh) 1995-10-24
PT96852B (pt) 1998-07-31
RU2083561C1 (ru) 1997-07-10
NO910735D0 (no) 1991-02-25
AU629453B2 (en) 1992-10-01
IE67801B1 (en) 1996-05-01
IE910625A1 (en) 1991-08-28
JP3157007B2 (ja) 2001-04-16
PT96852A (pt) 1991-10-31
KR100208114B1 (ko) 1999-07-15
JPH04217662A (ja) 1992-08-07
EP0444852A3 (en) 1992-02-19
LV10251B (en) 1995-04-20
CA2037099C (en) 2001-09-11
CA2037099A1 (en) 1991-08-27
FI95464C (fi) 1996-02-12
TW219933B (esLanguage) 1994-02-01
SG69975A1 (en) 2000-01-25
FI95464B (fi) 1995-10-31
DE69112099T2 (de) 1996-02-08
US5397799A (en) 1995-03-14
AU7197191A (en) 1991-08-29
EP0444852A2 (en) 1991-09-04
ZA911258B (en) 1992-10-28
HUT56542A (en) 1991-09-30
NZ237181A (en) 1992-06-25
EP0444852B1 (en) 1995-08-16
CY1887A (en) 1996-04-05
BR9100767A (pt) 1991-10-29
ES2077796T3 (es) 1995-12-01
LV10251A (lv) 1994-10-20
ATE126506T1 (de) 1995-09-15
NO910735L (no) 1991-08-27

Similar Documents

Publication Publication Date Title
EP0444852B1 (en) Crystalline salt of 4-(di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz[cd]indole
CA2029265C (en) 4- and 6-carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments
FI87785C (fi) Foerfarande foer framstaellning av farmaceutiskt aktivt, kristallint paroxetinhydrokloridhemihydrat
KR101468827B1 (ko) 카베딜롤 인산염 및(또는) 그의 용매화물, 상응하는 조성물, 및(또는) 치료 방법
CA2110574A1 (en) Tryptamine analogues, their synthesis and their use as 5-ht1-like or 5-ht2 receptor agonists
US6706710B2 (en) Form of (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide
HU204053B (en) Process for producing eseroline derivatives and pharmaceutical compositions comprising such compounds as active ingredient
JP3898219B2 (ja) フエニルインドール化合物
KR20030042038A (ko) 온단세트론 히드로클로라이드의 신규한 결정 형태 및용매화물 형태와 이들의 제조 방법
BG61186B1 (bg) Цис-2,3,3а,4,5,9в-хексахидро-1н-бензо(е)- индолови производни
US4452802A (en) Antihypertensive spiro[benzofuran-azalkanes]
CA2372236A1 (en) Polymorphs of crystalline (2-benzhydryl-1-azabicyclo¬2,2,2|oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists
US3474093A (en) Enamine adducts of n-acyloxy-n-acylaminoacetanilide
PT1499623E (pt) ''processo papa a preparação de 1, 2, 3, 9-tetra-hidro-9-metil-3- [(2-metil-1h-imidazol-1-il) metil] -4h-carbazol-4-ona''
JPH07188218A (ja) 大脳機能活性剤ｂｍｙ−２１５０２ヘミ水和物
EA011894B1 (ru) Новая псевдополиморфная форма деслоратадина, образованная с диоксидом углерода
EP1768969B1 (en) Crystalline mycophenolate sodium
KR20050019792A (ko) 카베딜롤 인산염 및(또는) 그의 용매화물, 상응하는조성물, 및(또는) 치료 방법
HU226912B1 (en) New paroxetin salt and medicament containing it
NZ245707A (en) Substituted indole derivatives

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070226